Microbiome Modulation in Cancer Prevention, Personalized Nutrition, and Precision Medicine
Advances in Experimental Medicine and Biology · 2026 · 91-119
DOI: 10.1007/978-981-92-0010-8_4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Experimental Medicine and Biology, online erschienen am 02.07.2026. Verfasst von Monica Arora und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, Villa College, Malé, Republic of Maldives. monica.arora@villacollege.edu.mv. Hauptthemen laut MEDLINE: Precision Medicine, Neoplasms, Gastrointestinal Microbiome. Die Arbeit nennt 156 Literaturangaben.
Abstract (Originalsprache)
Human microbiome which is a dynamic ecosystem of trillions of microorganisms is important in health and disease, especially in the establishment of cancer in ways such as through inflammation, generation of genotoxins, and immune modulation. This report aims to discuss the concept of microbiome modulation as a preventive and curative approach to cancer along with personalized nutrition and precision medicine. Dysbiosis is also associated with several types of cancers, such as colorectal, breast, and pancreatic whereby pathobionts, such as Fusobacterium nucleatum contribute to tumorigenesis, and beneficial taxa induce protective metabolites such as short-chain fatty acids. Eubiosis is restored through modulation methods such as probiotics, prebiotics, synbiotics, fecal microbiota transplantation, selective antibiotics, and dietary interventions and increase the efficacy of immunotherapy and decrease immunotherapy resistance. Anticancer properties of natural products, including curcumin, resveratrol, and berberine, can be summed up by their capacity to moderate microbiota in terms of achieving anti-inflammatory phenotypes. Gut microbes metabolically modify the food substances to produce bioactive metabolite, which affects the host immunity and epigenetics. Precision nutrition is a system that directs individuals to make diets based on multiomics data, microbiomics included, thereby predicting reactions and avoiding chronic diseases. Genome-scale reconstructions of metabolic models and machine learning computational models mimic these interactions to make personalized predictions. The problems are variability of microbiomes, standardization of data, ethical issues, and causality. In sum, this synthesis provides evidence that the microbiome can help make oncology a treatment centered on reaction to health issues but prevention based on individual needs and subjected to artificial intelligence personalization to allow administering the highest quality health to all the patients. Graphical Abstract Flow chart illustrating the relationship between external factors and gut dysbiosis, leading to increased cancer risk. External factors include diet, antibiotics, age, geography, lifestyle, and genetics. Gut dysbiosis is characterized by decreased diversity and increased pathobionts. This can lead to increased cancer risk, including colorectal, breast, pancreatic, prostate, and melanoma. The chart shows pathways for microbiome modulation through pro/pre/synbiotics and selective antibiotics, and the use of natural products like curcumin and resveratrol. These interventions aim to restore eubiosis and produce bioactive metabolites. Multi-omics profiling and precision nutrition are highlighted for cancer prevention and enhanced therapy, focusing on inflammation reduction, genotoxin exposure, and improved treatment responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Health Sciences, Villa College, Malé, Republic of Maldives. monica.arora@villacollege.edu.mv.
- Department of Pharmaceutical Sciences, School of Health Sciences and Technology, UPES, Dehradun, Uttarakhand, India.
- School of Pharmacy, Chitkara University Baddi, Solan, Himachal Pradesh, India.
- Department of Pharmaceutical Sciences, University of Science and Technology Meghalaya, Ri Bhoi, Meghalaya, India.
Zitieren
APA
Arora, M., Gaurav, A., Chaudhary, A., & Laskar, T. T. (2026). Microbiome Modulation in Cancer Prevention, Personalized Nutrition, and Precision Medicine. Advances in Experimental Medicine and Biology, 91-119. https://doi.org/10.1007/978-981-92-0010-8_4
Vancouver
Arora M, Gaurav A, Chaudhary A, Laskar TT. Microbiome Modulation in Cancer Prevention, Personalized Nutrition, and Precision Medicine. Advances in Experimental Medicine and Biology. 2026:91-119. doi:10.1007/978-981-92-0010-8_4
BibTeX
@article{Arora2026,
author = {Arora, Monica and Gaurav, Anand and Chaudhary, Amit and Laskar, Tanjima Tarique},
title = {Microbiome Modulation in Cancer Prevention, Personalized Nutrition, and Precision Medicine},
journal = {Advances in Experimental Medicine and Biology},
year = {2026},
pages = {91--119},
doi = {10.1007/978-981-92-0010-8_4}
}
EUVIMED